![Median overall survival according to CA 19-9 serum level baseline level. | Download Scientific Diagram Median overall survival according to CA 19-9 serum level baseline level. | Download Scientific Diagram](https://www.researchgate.net/publication/240307282/figure/fig1/AS:216448275357696@1428616698105/Median-overall-survival-according-to-CA-19-9-serum-level-baseline-level.png)
Median overall survival according to CA 19-9 serum level baseline level. | Download Scientific Diagram
![Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes - ScienceDirect Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1499387218300900-gr4.jpg)
Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes - ScienceDirect
![Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy](https://www.frontiersin.org/files/Articles/52319/fonc-03-00155-HTML/image_m/fonc-03-00155-g002.jpg)
Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy
![The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases. | Semantic Scholar The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/774e78614b2aab775f3493d19d9ef2cdd99429ad/3-Table1-1.png)
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases. | Semantic Scholar
![CA19-9 Levels in Saliva and Urine of Patients with Ductal Adenocarcinoma of the Pancreas Correlates with Serum CA19-9 Levels - A Prospective Preliminary Study CA19-9 Levels in Saliva and Urine of Patients with Ductal Adenocarcinoma of the Pancreas Correlates with Serum CA19-9 Levels - A Prospective Preliminary Study](https://www.primescholars.com/articles-images/pancreas-17-1-11-t001.png)
CA19-9 Levels in Saliva and Urine of Patients with Ductal Adenocarcinoma of the Pancreas Correlates with Serum CA19-9 Levels - A Prospective Preliminary Study
![Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages | Life Science Alliance Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages | Life Science Alliance](https://www.life-science-alliance.org/content/lsa/4/6/e202000935/F14.large.jpg)
Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages | Life Science Alliance
![PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f7bb4eb6de25f6ecb9323cbef8061896f020a0da/2-Table1-1.png)
PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar
![Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer | British Journal of Cancer Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2011.453/MediaObjects/41416_2011_Article_BFbjc2011453_Fig1_HTML.jpg)
Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer | British Journal of Cancer
![Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis - eBioMedicine Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis - eBioMedicine](https://www.thelancet.com/cms/attachment/c7b479be-8950-4e26-a29e-c817465360b1/gr1_lrg.jpg)
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis - eBioMedicine
![Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma | Scientific Reports Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-80778-0/MediaObjects/41598_2020_80778_Fig1_HTML.png)
Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma | Scientific Reports
Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin | PLOS ONE
![Serum levels of hematopoietic cytokines and tumor markers in pancreatic... | Download Scientific Diagram Serum levels of hematopoietic cytokines and tumor markers in pancreatic... | Download Scientific Diagram](https://www.researchgate.net/publication/6559102/figure/tbl1/AS:786298558230530@1564479593763/Serum-levels-of-hematopoietic-cytokines-and-tumor-markers-in-pancreatic-cancer-patients.png)